| Date Filed | Type | Description |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $4.01, valued at
$641.6k
|
|
| 12/16/2019 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $3.54, valued at
$566.4k
|
|
| 06/10/2019 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 15,500 shares
@ $3.56, valued at
$55.2k
Bought 10,000 shares
@ $3.38, valued at
$33.8k
|
|
| 12/27/2018 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 24,700 shares
@ $4.1461, valued at
$102.4k
|
|
| 12/14/2018 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.94, valued at
$594k
|
|
| 12/15/2017 |
4
| LEA LEIV (CFO) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $10.6, valued at
$424k
|
|
| 02/10/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |